MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

10 Feb 2023 Evaluate
A decrease in the sales to Rs. 697.98 millions was observed for the quarter ended December 2022. The sales stood at Rs. 813.67 millions during the similar quarter previous year.Profit after Tax for the quarter ended December 2022 saw a decline of -43.84% from Rs. 108.50 millions to Rs. 60.93  millions.Operating Profit reported a sharp decline to 103.81 millions from 164.54 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 697.98 813.67 -14.22 1976.88 2357.73 -16.15 3186.67 2552.07 24.87
Other Income 29.52 44.07 -33.02 106.98 142.16 -24.75 126.40 115.21 9.71
PBIDT 103.81 164.54 -36.91 223.54 659.37 -66.10 782.09 852.30 -8.24
Interest 2.57 4.16 -38.22 8.75 11.88 -26.35 15.62 18.40 -15.11
PBDT 101.24 160.38 -36.87 214.79 647.49 -66.83 766.47 833.90 -8.09
Depreciation 20.04 19.04 5.25 59.81 57.93 3.25 76.73 73.94 3.77
PBT 81.20 141.34 -42.55 154.98 589.56 -73.71 689.74 759.96 -9.24
TAX 20.27 32.84 -38.28 39.29 145.68 -73.03 167.28 205.28 -18.51
Deferred Tax 2.26 -4.17 -154.20 -3.32 4.67 -171.09 -4.22 14.58 -128.94
PAT 60.93 108.50 -43.84 115.69 443.88 -73.94 522.46 554.68 -5.81
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 14.87 20.22 -26.45 11.31 27.97 -59.57 24.54 33.40 -26.51
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..